GlassScriptPhysician profile
Milan Sanghavi
NPI 1497967277
$144,673.77
in general payments reported to CMS, 2019-2025
77 companies · $46K in 2025
The $46K reported for 2025 was more than what 96% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,408 · 2020: $12K · 2021: $20K · 2022: $26K · 2023: $9,022 · 2024: $29K · 2025: $46K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $67K · Food and Beverage: $13K · Travel and Lodging: $1,941 · Consulting Fee: $1,525 · Education: $13.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $67,285.00 |
| Food and Beverage | $13,249.56 |
| Travel and Lodging | $1,941.00 |
| Consulting Fee | $1,525.00 |
| Education | $13.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $52,738.47 | 2019-2025 | Kisunla, Emgality, Reyvow |
| Abbvie INC. | $38,001.51 | 2021-2025 | Ubrelvy, Qulipta, Botox |
| Biohaven Pharmaceutical Holding Company LTD. | $12,809.66 | 2022 | |
| Allergan, INC. | $12,485.87 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $6,870.35 | 2020-2021 | |
| Pfizer INC. | $5,306.26 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $1,883.13 | 2019-2025 | |
| Biogen, INC. | $1,240.24 | 2019-2025 | Vumerity, Tysabri, Avonex |
| Lundbeck LLC | $1,001.00 | 2019-2025 | Vyepti, Rexulti |
| Ucb, INC. | $962.32 | 2019-2025 | Rystiggo, Zilbrysq, Briviact |
| Sunovion Pharmaceuticals INC. | $740.96 | 2019-2022 | |
| Eisai INC. | $650.28 | 2019-2025 | |
| Emd Serono, INC. | $576.60 | 2019-2025 | Mavenclad |
| Teva Pharmaceuticals USA, INC. | $522.68 | 2019-2023 | Austedo |
| Takeda Pharmaceuticals U.S.A., INC. | $469.31 | 2020-2025 | Hyqvia, Gammagard |
Show all 77 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $455.92 | 2019-2025 | Gamunex-C |
| Sumitomo Pharma America, INC. | $430.24 | 2023-2024 | Aptiom |
| Csl Behring | $429.75 | 2019-2025 | Hizentra |
| Genzyme Corporation | $414.34 | 2019-2025 | |
| Amgen INC. | $410.44 | 2019-2025 | Uplizna |
| Alexion Pharmaceuticals, INC. | $374.67 | 2019-2025 | Ultomiris |
| Jazz Pharmaceuticals INC. | $332.52 | 2019-2025 | |
| Acadia Pharmaceuticals INC | $332.37 | 2019-2025 | Nuplazid |
| Harmony Biosciences LLC | $330.85 | 2021-2025 | |
| Sk Life Science, INC. | $309.31 | 2022-2025 | |
| Argenx US, INC. | $301.83 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Neurelis, INC. | $281.78 | 2022-2025 | Valtoco |
| Amneal Pharmaceuticals LLC | $273.59 | 2019-2025 | Crexont, Rytary |
| Neurocrine Biosciences, INC. | $238.33 | 2022-2025 | Ingrezza, Ongentys |
| Horizon Therapeutics Plc | $211.76 | 2022-2023 | Uplizna |
| Axsome Therapeutics, INC. | $210.08 | 2023-2025 | Sunosi, Symbravo |
| Celgene Corporation | $206.61 | 2022-2025 | Zeposia |
| Catalyst Pharmaceuticals, INC. | $193.06 | 2022-2024 | Fycompa |
| Genentech USA, INC. | $190.07 | 2022-2025 | Ocrevus Zunovo, Ocrevus |
| Tanabe Pharma America, INC. | $186.49 | 2022-2025 | Radicava |
| Banner Life Sciences, LLC | $159.21 | 2021-2024 | |
| Acorda Therapeutics, INC | $127.94 | 2019-2023 | Ampyra, Inbrija |
| Avanir Pharmaceuticals, INC. | $116.83 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $112.21 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $109.85 | 2022-2025 | Ponvory |
| Alnylam Pharmaceuticals INC. | $109.75 | 2022-2023 | Onpattro |
| Kyowa Kirin, INC. | $97.52 | 2021-2024 | Nourianz |
| Otsuka America Pharmaceutical, INC. | $93.01 | 2023-2024 | Rexulti, Nuedexta |
| Shire North American Group INC | $89.59 | 2019 | |
| Mdd US Operations, LLC | $87.61 | 2022 | |
| Adamas Pharmaceuticals, INC. | $87.51 | 2019-2021 | |
| Impel Pharmaceuticals INC. | $87.12 | 2023 | Trudhesa |
| Upsher-Smith Laboratories LLC | $82.95 | 2019-2020 | |
| Ge Healthcare | $63.67 | 2019-2020 | |
| Kedrion Biopharma, INC. | $62.79 | 2025 | Koate, Gammaked, Kedrab |
| Supernus Pharmaceuticals, INC. | $61.70 | 2022-2025 | Qelbree |
| Medtronic USA, INC. | $59.72 | 2019 | |
| Sanofi-Aventis U.S. LLC | $53.07 | 2019-2020 | |
| Life Molecular Imaging LTD | $51.44 | 2023-2024 | Neuraceq |
| Nevro Corp. | $48.47 | 2022-2023 | Senza |
| Avadel Cns Pharmaceuticals, LLC | $43.96 | 2023-2025 | Lumryz |
| Avion Pharmaceuticals | $41.54 | 2022 | |
| Almatica Pharma LLC | $39.15 | 2021-2023 | Gralise |
| Impel Pharmaceuticals LLC | $36.26 | 2024 | Trudhesa |
| Currax Pharmaceuticals LLC | $30.01 | 2025 | Onzetra Xsail, Contrave |
| Ani Pharmaceuticals, INC. | $28.58 | 2025 | Purified Cortrophin Gel |
| Inspire Medical Systems, INC. | $28.49 | 2025 | Inspire |
| Idorsia Pharmaceuticals US INC | $27.48 | 2022-2024 | Quviviq |
| Saluda Medical Americas, INC. | $27.46 | 2024 | Evoke |
| Arbor Pharmaceuticals, INC. | $22.51 | 2022 | |
| Averitas Pharma INC. | $22.42 | 2023 | Qutenza |
| Scilex Pharmaceuticals INC. | $21.78 | 2023 | Ztlido |
| Merz Pharmaceuticals, LLC | $21.40 | 2023 | Xeomin |
| Vertos Medical, INC. | $20.79 | 2024 | Mild Device Kit |
| Tg Therapeutics, INC. | $20.52 | 2023 | |
| Merck Sharp & Dohme LLC | $17.47 | 2021 | |
| Amarin Pharma, INC. | $16.18 | 2019 | |
| Akcea Therapeutics, INC. | $16.03 | 2020 | |
| Zyla Life Sciences, INC. | $15.51 | 2019 | |
| Mallinckrodt Hospital Products INC. | $14.13 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $13.75 | 2021 | |
| Resmed Corp | $13.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Milan Sanghavi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.